Center for Neurologic Study, La Jolla, California, Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2013
NCT01806857
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now